295 related articles for article (PubMed ID: 24742729)
1. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
Barry V; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
[TBL] [Abstract][Full Text] [Related]
2. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
Winquist A; Steenland K
Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
[TBL] [Abstract][Full Text] [Related]
3. Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort.
Dhingra R; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Apr; 146():323-30. PubMed ID: 26802619
[TBL] [Abstract][Full Text] [Related]
4. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
Steenland K; Zhao L; Winquist A; Parks C
Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
[TBL] [Abstract][Full Text] [Related]
5. Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant.
Simpson C; Winquist A; Lally C; Steenland K
Environ Res; 2013 Nov; 127():22-8. PubMed ID: 24199934
[TBL] [Abstract][Full Text] [Related]
6. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers.
Winquist A; Lally C; Shin HM; Steenland K
Environ Health Perspect; 2013 Aug; 121(8):893-9. PubMed ID: 23735518
[TBL] [Abstract][Full Text] [Related]
7. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community.
Savitz DA; Stein CR; Bartell SM; Elston B; Gong J; Shin HM; Wellenius GA
Epidemiology; 2012 May; 23(3):386-92. PubMed ID: 22370857
[TBL] [Abstract][Full Text] [Related]
8. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant.
Barry V; Winquist A; Steenland K
Environ Health Perspect; 2013; 121(11-12):1313-8. PubMed ID: 24007715
[TBL] [Abstract][Full Text] [Related]
9. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community.
Seals R; Bartell SM; Steenland K
Environ Health Perspect; 2011 Jan; 119(1):119-24. PubMed ID: 20870569
[TBL] [Abstract][Full Text] [Related]
10. Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.
Darrow LA; Groth AC; Winquist A; Shin HM; Bartell SM; Steenland K
Environ Health Perspect; 2016 Aug; 124(8):1227-33. PubMed ID: 26978841
[TBL] [Abstract][Full Text] [Related]
11. Perfluorooctanoic acid and chronic kidney disease: Longitudinal analysis of a Mid-Ohio Valley community.
Dhingra R; Lally C; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Feb; 145():85-92. PubMed ID: 26656498
[TBL] [Abstract][Full Text] [Related]
12. Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid.
Karnes C; Winquist A; Steenland K
Environ Res; 2014 Jan; 128():78-83. PubMed ID: 24299613
[TBL] [Abstract][Full Text] [Related]
13. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.
Steenland K; Tinker S; Frisbee S; Ducatman A; Vaccarino V
Am J Epidemiol; 2009 Nov; 170(10):1268-78. PubMed ID: 19846564
[TBL] [Abstract][Full Text] [Related]
14. Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project.
Kerger BD; Copeland TL; DeCaprio AP
Drug Chem Toxicol; 2011 Oct; 34(4):396-404. PubMed ID: 21770727
[TBL] [Abstract][Full Text] [Related]
15. PFOA and PFOS serum levels and miscarriage risk.
Darrow LA; Howards PP; Winquist A; Steenland K
Epidemiology; 2014 Jul; 25(4):505-12. PubMed ID: 24807698
[TBL] [Abstract][Full Text] [Related]
16. A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes.
Dhingra R; Winquist A; Darrow LA; Klein M; Steenland K
Environ Health Perspect; 2017 Mar; 125(3):416-421. PubMed ID: 27529882
[TBL] [Abstract][Full Text] [Related]
17. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature.
Post GB; Cohn PD; Cooper KR
Environ Res; 2012 Jul; 116():93-117. PubMed ID: 22560884
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA).
MacNeil J; Steenland NK; Shankar A; Ducatman A
Environ Res; 2009 Nov; 109(8):997-1003. PubMed ID: 19740462
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
Worley RR; Yang X; Fisher J
Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
[TBL] [Abstract][Full Text] [Related]
20. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.
Hoffman K; Webster TF; Bartell SM; Weisskopf MG; Fletcher T; Vieira VM
Environ Health Perspect; 2011 Jan; 119(1):92-7. PubMed ID: 20920951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]